Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Top Cited Papers
- 18 October 2010
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 11 (11), 1048-1056
- https://doi.org/10.1016/s1470-2045(10)70230-8
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinantsInternational Journal of Cancer, 2009
- Human Papillomavirus Genotype Distributions: Implications for Vaccination and Cancer Screening in the United StatesJNCI Journal of the National Cancer Institute, 2009
- A review of human carcinogens—Part B: biological agentsThe Lancet Oncology, 2009
- Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian womenBritish Journal of Cancer, 2009
- Different outcome of invasive cervical cancer associated with high‐risk versus intermediate‐risk HPV genotypeInternational Journal of Cancer, 2008
- A Systematic Review of the Prevalence and Attribution of Human Papillomavirus Types among Cervical, Vaginal, and Vulvar Precancers and Cancers in the United StatesCancer Epidemiology, Biomarkers & Prevention, 2008
- Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis updateInternational Journal of Cancer, 2007
- The Elevated 10-Year Risk of Cervical Precancer and Cancer in Women With Human Papillomavirus (HPV) Type 16 or 18 and the Possible Utility of Type-Specific HPV Testing in Clinical PracticeJNCI Journal of the National Cancer Institute, 2005
- Against which human papillomavirus types shall we vaccinate and screen? the international perspectiveInternational Journal of Cancer, 2004
- Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical CancerNew England Journal of Medicine, 2003